Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New 6-factor prognostic model for patients (pts) with advanced urothelial carcinoma (UC) receiving post-platinum atezolizumab. Pond, G., Niegisch, G., Rosenberg, J. E., Dreicer, R., Powles, T., Necchi, A., Wei, X. X., Grivas, P., Balar, A., Galsky, M. D., Srinivas, S., Choueiri, T. K., Bellmunt, J., Bajorin, D. F., Sonpavde, G. AMER SOC CLINICAL ONCOLOGY. 2018
View details for DOI 10.1200/JCO.2018.36.6_suppl.413
View details for Web of Science ID 000436179500407